Last update Feb. 12, 2020

Maternal Fibrocystic breast disease

Compatible

Safe substance and/or breastfeeding is the best option.

Fibrocystic breasts are benign changes in breast tissue that occur in more than half of women and consist of the appearance of cysts, nodules and multiple thickening in both breasts that change in size with the menstrual cycle.
They can cause pain and increased sensitivity to touch, especially in the upper outer quadrant of the breast.
They are due to a benign proliferation of the alveolar system of hormonal origin (Brkic 2018, MedlinePlus 2018).

There may be bloody or greenish-brown discharge from the nipple. A case of vomiting of blood has been reported in an infant whose mother had fibrocystic breasts (Aksoy 2013).

Ultrasound and puncture biopsy may be required for diagnosis, especially if there are nodules larger than 2 cm.

Anti-inflammatories such as ibuprofen or paracetamol and oral contraceptives used for treatment are compatible with breastfeeding. No other treatment or dietary restriction is effective (Rohan 2008).

Symptomatology may appear during breastfeeding, but is not influenced by it (Bernardi 2012). Fibrocystic breasts do not contraindicate breastfeeding (Lawrence 2016 p610).

Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.
DONATE NOW

Other names

Maternal Fibrocystic breast disease is also known as


Group

Maternal Fibrocystic breast disease belongs to this group or family:

References

  1. Brkić M, Vujović S, Ivović M, Tančić Gajić M, Marina L, Franić Ivanišević M, Franić D. THE ROLE OF E2/P RATIO IN THE ETIOLOGY OF FIBROCYSTIC BREAST DISEASE, MASTALGIA AND MASTODYNIA. Acta Clin Croat. 2018 Dec;57(4):756-761. Abstract
  2. MedlinePlus. Cambios fibroquísticos en las mamas. Información de salud para usted. 2018 Full text (link to original source) Full text (in our servers)
  3. MedlinePlus. Fibrocystic breast disease. Trusted Health information for you. 2018 Full text (link to original source) Full text (in our servers)
  4. Lawrence RA, Lawrence RM. Breastfeeding. A guide for the medical profession. Eighth Edition. Philadelphia: Elsevier; 2016
  5. Lawrence RM. Circumstances when breastfeeding is contraindicated. Pediatr Clin North Am. 2013 Feb;60(1):295-318. Abstract
  6. Aksoy HT, Eras Z, Erdeve O, Dilmen U. A rare cause of hematemesis in newborn: fibrocystic breast disease of mother. Breastfeed Med. 2013 Aug;8(4):418-20. Abstract
  7. Bernardi S, Londero AP, Bertozzi S, Driul L, Marchesoni D, Petri R. Breast-feeding and benign breast disease. J Obstet Gynaecol. 2012 Jan;32(1):58-61. Abstract
  8. Rohan TE, Negassa A, Caan B, Chlebowski RT, Curb JD, Ginsberg M, Lane DS, Neuhouser ML, Shikany JM, Wassertheil-Smoller S, Page DL. Low-fat dietary pattern and risk of benign proliferative breast disease: a randomized, controlled dietary modification trial. Cancer Prev Res (Phila). 2008 Sep;1(4):275-84. Abstract

Total visits

39,637

Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write us at elactancia.org@gmail.com

e-lactancia is a resource recommended by El Parto Es Nuestro of Spain

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM